Repare Therapeutics Inc. General and Administrative Expense
Repare Therapeutics Inc. reported General and Administrative Expense of $4.55 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2025-11-14
- Repare Therapeutics Inc. general and administrative expense for the quarter ending 2025-09-30 was $4.55M, a 29.42% decline year-over-year.
- Repare Therapeutics Inc. general and administrative expense for the quarter ending 2025-06-30 was $6.03M, a 27.51% decline year-over-year.
- Repare Therapeutics Inc. general and administrative expense for the quarter ending 2025-03-31 was $7.65M, a 11.21% decline year-over-year.
- Repare Therapeutics Inc. general and administrative expense for the quarter ending 2024-12-31 was $6.30M, a 27.14% decline year-over-year.
- Repare Therapeutics Inc. general and administrative expense for fiscal 2024 was $29.68M, a 12.10% decline from fiscal 2023.
- Repare Therapeutics Inc. general and administrative expense for fiscal 2023 was $33.76M, a 3.70% increase from fiscal 2022.
- Repare Therapeutics Inc. general and administrative expense for fiscal 2022 was $32.56M, a 24.21% increase from fiscal 2021.
- Repare Therapeutics Inc. general and administrative expense for fiscal 2021 was $26.21M, a 82.72% increase from fiscal 2020.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $4.55M 10-Q · filed 2025-11-14 | $10.58M derived: sum of 2 quarters · filed 2025-11-14 | $18.23M 10-Q · filed 2025-11-14 | $24.53M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $6.03M 10-Q · filed 2025-08-08 | $13.68M 10-Q · filed 2025-08-08 | $19.98M derived: sum of 3 quarters · filed 2025-08-08 | $26.43M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | $7.65M 10-Q · filed 2025-05-13 | $13.95M derived: sum of 2 quarters · filed 2025-05-13 | $20.40M derived: sum of 3 quarters · filed 2025-11-14 | $28.71M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $12.74M derived: sum of 2 quarters · filed 2025-11-14 | $21.06M derived: sum of 3 quarters · filed 2025-11-14 | $29.68M 10-K · filed 2025-03-03 |
| 2024-09-30 | $6.44M 10-Q · filed 2025-11-14 | $14.76M derived: sum of 2 quarters · filed 2025-11-14 | $23.38M 10-Q · filed 2025-11-14 | $32.03M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $8.32M 10-Q · filed 2025-08-08 | $16.93M 10-Q · filed 2025-08-08 | $25.58M derived: sum of 3 quarters · filed 2025-08-08 | $33.45M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $8.62M 10-Q · filed 2025-05-13 | $17.27M derived: sum of 2 quarters · filed 2025-05-13 | $25.13M derived: sum of 3 quarters · filed 2025-05-13 | $33.85M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $8.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $16.52M derived: sum of 2 quarters · filed 2025-03-03 | $25.23M derived: sum of 3 quarters · filed 2025-03-03 | $33.76M 10-K · filed 2025-03-03 |
| 2023-09-30 | $7.87M 10-Q · filed 2024-11-07 | $16.59M derived: sum of 2 quarters · filed 2024-11-07 | $25.12M 10-Q · filed 2024-11-07 | $33.05M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $8.72M 10-Q · filed 2024-08-06 | $17.25M 10-Q · filed 2024-08-06 | $25.19M derived: sum of 3 quarters · filed 2024-08-06 | $33.09M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $8.53M 10-Q · filed 2024-05-07 | $16.47M derived: sum of 2 quarters · filed 2024-05-07 | $24.37M derived: sum of 3 quarters · filed 2024-05-07 | $32.31M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $15.84M derived: sum of 2 quarters · filed 2024-02-28 | $23.78M derived: sum of 3 quarters · filed 2024-02-28 | $32.56M 10-K · filed 2024-02-28 |
| 2022-09-30 | $7.90M 10-Q · filed 2023-11-09 | $15.84M derived: sum of 2 quarters · filed 2023-11-09 | $24.62M 10-Q · filed 2023-11-09 | $32.26M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $7.94M 10-Q · filed 2023-08-09 | $16.72M 10-Q · filed 2023-08-09 | $24.36M derived: sum of 3 quarters · filed 2023-08-09 | $30.95M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $8.78M 10-Q · filed 2023-05-09 | $16.42M derived: sum of 2 quarters · filed 2023-05-09 | $23.01M derived: sum of 3 quarters · filed 2023-05-09 | $29.75M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $7.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $14.23M derived: sum of 2 quarters · filed 2023-02-28 | $20.98M derived: sum of 3 quarters · filed 2023-02-28 | $26.21M 10-K · filed 2023-02-28 |
| 2021-09-30 | $6.60M 10-Q · filed 2022-11-09 | $13.34M derived: sum of 2 quarters · filed 2022-11-09 | $18.57M 10-Q · filed 2022-11-09 | $23.37M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $6.74M 10-Q · filed 2022-08-04 | $11.98M 10-Q · filed 2022-08-04 | $16.77M derived: sum of 3 quarters · filed 2022-08-04 | $20.77M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $5.24M 10-Q · filed 2022-05-05 | $10.03M derived: sum of 2 quarters · filed 2022-05-05 | $14.03M derived: sum of 3 quarters · filed 2022-05-05 | $17.40M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.79M derived: sum of 2 quarters · filed 2022-03-01 | $12.16M derived: sum of 3 quarters · filed 2022-03-01 | $14.35M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.00M 10-Q · filed 2021-11-10 | $7.37M derived: sum of 2 quarters · filed 2021-11-10 | $9.55M 10-Q · filed 2021-11-10 | $11.57M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $3.37M 10-Q · filed 2021-08-12 | $5.55M 10-Q · filed 2021-08-12 | $7.58M derived: sum of 3 quarters · filed 2022-03-01 | $8.83M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.18M 10-Q · filed 2021-05-13 | $4.21M derived: sum of 2 quarters · filed 2022-03-01 | $5.46M derived: sum of 3 quarters · filed 2022-03-01 | $6.49M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.27M derived: sum of 2 quarters · filed 2022-03-01 | $4.31M derived: sum of 3 quarters · filed 2022-03-01 | $5.38M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.25M 10-Q · filed 2020-11-12 | $2.28M derived: sum of 2 quarters · filed 2020-11-12 | $3.36M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $1.03M 10-Q · filed 2020-08-13 | $2.11M 10-Q · filed 2020-08-13 |